Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 EUR | 0.00% | 0.00% | -68.66% |
Business Summary
Export accounts for 69.3% of net sales.
Number of employees: 21
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ronan Boulme
CEO | Chief Executive Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Laure Raffaelli
BRD | Director/Board Member | - | - |
Noemie Sadoun
CHM | Chairman | - | - |
Deborah Szafir
BRD | Director/Board Member | - | - |
Carlos Freixas
BRD | Director/Board Member | - | - |
Bertrand Aulong
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 16,114,656 | 57,880 ( 0.3592 %) | 752 ( 0.004667 %) | 0.3592 % |
Company contact information
ABL Diagnostics SA
42, rue Olivier Métra - Bat E1
75020, Paris
+33 3 87 17 81 56
http://www.fauvet-girel.frSector
1st Jan change | Capi. | |
---|---|---|
-68.66% | 53.12M | |
-6.43% | 178B | |
-1.16% | 107B | |
-2.45% | 67.04B | |
-7.40% | 47.23B | |
+11.50% | 44.62B | |
+9.25% | 42.5B | |
+14.87% | 29.99B | |
+15.97% | 25.22B | |
-7.45% | 24.14B |
- Stock Market
- Equities
- ABLD Stock
- Company ABL Diagnostics